Aim: The aim of this study was to determine if nevus-associated melanoma differs in characteristics and prognosis from de novo melanoma.

Patients And Methods: The study included 118 melanoma patients. Clinical findings were retrospectively evaluated. For histopathological parameters, HE sections were reexamined. The differentiation between de novo and nevus-associated melanoma was based on the histopathological evidence of a precursor nevus. In addition, all analyses were repeated in all cases in which nevus-associated melanoma was defined based on patient anamnesis.

Results: Among all patients, 28 (23.7%) had nevus-associated melanoma. Nevus-associated melanoma was most commonly located on the extremities (50%), followed by the trunk (25%), whereas de novo melanoma was most commonly located in the head and neck region (32.2%), followed by the acral region (31.1%). Other clinical findings and histopathological parameters did not differ significantly between the two groups (p > 0.05). The findings remained consistent following the repeated analysis of all cases in which nevus-associated melanoma was defined based on patient anamnesis.

Conclusions: Nevus-associated melanoma was most commonly located on the extremities and the trunk, whereas de novo melanoma was most commonly located in the head and neck and the acral region. Furthermore, nevus-associated melanoma was similar to de novo melanoma in terms of prognosis and other disease characteristics.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816428PMC
http://dx.doi.org/10.1159/000375490DOI Listing

Publication Analysis

Top Keywords

nevus-associated melanoma
32
novo melanoma
16
melanoma commonly
16
commonly located
16
melanoma
13
nevus-associated
9
clinical findings
8
histopathological parameters
8
cases nevus-associated
8
melanoma defined
8

Similar Publications

Background: It is unknown whether acral melanomas (AMs) associated with pre-existing nevi have similar risk to other AMs.

Objective: To compare risk of recurrence and death between AMs associated with pre-existing nevi and de novo AMs.

Methods: We conducted a multicenter retrospective cohort study involving patients diagnosed with AMs between February 2011 and November 2022.

View Article and Find Full Text PDF

Melanoma arising in association with a blue nevus (BN) is rare but has molecular similarities to uveal melanoma (UM), including GNAQ/11 mutations. Tebentafusp was recently approved for UM based on improved overall survival in a phase 3 study. We hypothesized that tebentafusp may be active in BN-associated melanoma.

View Article and Find Full Text PDF
Article Synopsis
  • PRAME is an important marker that helps distinguish between benign dysplastic nevi (DN) and malignant nevus-associated melanoma in situ (MIS).
  • In a study of 172 DN and 38 MIS cases, 71.1% of MIS showed positive PRAME expression, while all DN were negative, with only 5.7% of DN cases showing any positivity.
  • The findings suggest that PRAME expression is particularly useful in identifying MIS that arise from DN, especially those with both epidermal and dermal components.
View Article and Find Full Text PDF

Primary leptomeningeal melanocytic neoplasms: A clinicopathologic, immunohistochemical, and molecular study of 12 cases.

Hum Pathol

June 2024

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China. Electronic address:

This study investigated the clinicopathological, immunohistochemical, and molecular features of primary leptomeningeal melanocytic neoplasms (LMNs). Twelve LMN cases were retrospectively reviewed. We performed Fluorescence in-situ hybridization (including a 4-probe FISH assay with CDKN2A and MYC assay) and Next-Generation sequencing analyses on available cases.

View Article and Find Full Text PDF

Nevus-associated Lentigo Maligna and Lentigo Maligna Melanoma, Clinicopathological Features.

Acta Derm Venereol

April 2024

Skin Cancer Center, Karolinska University Hospital, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.

Nevus-associated lentigo maligna and lentigo maligna melanoma (NALMM) are rarely described in the literature and are considered an incidental finding. This study aimed to evaluate the frequency of NALMM and its clinicopathological features. A total of 201 histopathology reports were reviewed and among them 20% of the samples corresponded to NALMM, with females overrepresented in this group (p = 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!